TABLE 3.
Group of KAT6B according to Radvanszky et al. (2017); Turkyilmaz and Ozden (2021); Vlckova et al. (2015) | Affected codons | Preducted effect | Phenotype | Polish genotype, number of patient | Polish phenotype, number of patient |
---|---|---|---|---|---|
1–2 | 1–1205 | NMD | SBBYSS/mild | 4 | 4 (SBBYSS) |
3 | 1205–1350 | Truncated protein | GPS | 1 and 2 | 1 (SBBYSS) and 2 (GPS/SBBYSS) |
4 | 1350–1520 | Truncated protein | GPS/SBBYSS/intermediate | 5 | 5 (SBBYSS) |
5 | 1520–1935 | Truncated protein | SBBYSS | 6 | 6 (GPS/SBBYSS) |
6 (hypothesized) | Distal to p.1935 | Truncated protein | Unknown (SBBYSS/asymptomatic) | 3 | 3 (mild SBBYSS) |
Abbreviation: NMD, non‐mediated mRNA decay.